Global Market Study on Rheumatoid Arthritis Diagnosis Tests: Rheumatoid Factor (RF) Serology Tests Segment to Significantly Contribute to Global Market Growth in the Coming Years


  • Rep Id : XPLREP336
  • Published On : January, 2018
  • No. of Pages : 216
  • Category : Arthritis
  • Publisher : Persistence Market Research

Report Description

This This Market Study (PMR) report examines the rheumatoid arthritis market performance in terms of value and volume contribution. The report includes key trends, drivers, restraints, and opportunities influencing growth of the global rheumatoid arthritis market over forecast period (2016–2027). Impact analysis of key growth drivers and restraints based on the weighted average model are included in this report to better equip clients with crystal clear decision-making insights. Various types of kits used to ascertain amount of substance in samples across hospitals, diagnostic laboratories, ambulatory surgical centers have been considered in this report.

The Rheumatoid Arthritis Diagnosis Tests Market segmented as follows:

  • By Test Type
    • Serology Tests
    • Monitoring RA Treatment Efficiency Tests
  • By End User
    • Diagnostic Laboratories
    • Ambulatory Surgical Centers
    • Hospitals
  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific (APAC)
    • Middle East and Africa (MEA)

This report covers the global rheumatoid arthritis diagnosis tests market performance in terms of revenue contribution from various segments. This section also includes PMR analysis of key trends, drivers, restraints, and opportunities, which are influencing the growth of the global rheumatoid arthritis diagnosis tests market.  

The global rheumatoid arthritis diagnosis tests market report begins with an overview of the global rheumatoid arthritis diagnosis tests market. This section also underlines factors influencing growth of the global rheumatoid arthritis diagnosis tests market along with detailing of the key trends, drivers, restraints, opportunity and regulations. Impact analysis of key regional growth drivers and restraints based on the weighted average model along with key region-specific trends is included in report to better equip clients with information and hidden insights.

The global rheumatoid arthritis diagnosis tests market is segmented on the basis of test type, end user and region. By test type, the global rheumatoid arthritis diagnosis tests market is segmented into serology test and monitoring RA treatment efficiency monitoring tests. Serology test segment is further sub-segmented into erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP), antinuclear antibody (ANA), uric acid test, and other tests. RA treatment efficiency monitoring tests segment is further sub-segmented into Salicylate Level Count, Muscle Enzyme Tests (CPK, Aldolase), and Creatinine Test. A detailed analysis has been provided for every segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity, market attractive index.

By end user, the global rheumatoid arthritis diagnosis tests market is segmented into hospital, diagnostic laboratories, and ambulatory surgical centers. Diagnostic laboratory segment is further sub-segmented into private laboratories and public laboratories. The next section of the report highlights the growth trends of the rheumatoid arthritis diagnosis tests market by region. It provides a market outlook for 2012–2027 and sets the forecast within the context of the rheumatoid arthritis diagnosis tests market. The study discusses key regional trends contributing to growth of the rheumatoid arthritis diagnosis tests market worldwide, as well as analyses the extent to which drivers are influencing this market in each region. Key regions assessed in this report include North America, Latin America, Europe, Asia Pacific and MEA. APAC region is expected to emerge dominant and most attractive over the forecast period.    

The above sections – test type, end user and region – evaluate the present scenario and growth prospects of the rheumatoid arthritis diagnosis tests market for the period 2012–2027. We have considered 2016 as the base year and provided data for the forecast period.  

The final chapter in the report covers analysis on key competitors involved in this market. Detailed company profiles include company-specific long-term and short-term strategies, key offerings and recent developments in the rheumatoid arthritis diagnosis tests market.